Agilent Technologies (NYSE:A – Get Free Report) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided EPS guidance of 5.540-5.610 for the period, compared to the consensus EPS estimate of 5.660. The company issued revenue guidance of $6.8 billion-$6.9 billion, compared to the consensus revenue estimate of $6.8 billion. Agilent Technologies also updated its FY25 guidance to $5.54-5.61 EPS.
Agilent Technologies Trading Down 0.1 %
A opened at $134.35 on Wednesday. Agilent Technologies has a one year low of $124.10 and a one year high of $155.35. The stock has a market capitalization of $38.60 billion, a PE ratio of 27.87, a P/E/G ratio of 5.89 and a beta of 1.07. The business’s 50 day moving average price is $137.74 and its 200 day moving average price is $137.43. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78.
Agilent Technologies Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be issued a $0.248 dividend. The ex-dividend date is Tuesday, December 31st. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 dividend on an annualized basis and a yield of 0.74%. Agilent Technologies’s dividend payout ratio is currently 19.50%.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on A
Insider Activity
In related news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at $5,801,595. This represents a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Recommended Stories
- Five stocks we like better than Agilent Technologies
- How to Read Stock Charts for Beginners
- Gold vs. Silver: Profit Opportunities in the Widening Spread
- Industrial Products Stocks Investing
- Semler Stock Surges Over 130% in November: A New Bitcoin Play?
- 3 Fintech Stocks With Good 2021 Prospects
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.